Publications by authors named "Ash Jain"

Claim this Profile
S
Stellarex Drug-Coated Balloon for the Treatment of Peripheral Artery Disease: Five-Year Results from the ILLUMENATE Pivotal Randomized Controlled Trial.
Prakash Krishnan, Peter Faries, Khusrow Niazi, Ravish Sachar, Ash Jain

Am J Cardiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes.
Sean P Lyden, Peter L Faries, Khusrow A K Niazi, Ravish Sachar, Ash Jain

J Endovasc Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
Prakash Krishnan, Peter Faries, Khusrow Niazi, Ash Jain, Ravish Sachar

Circulation· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Study on National Institutes of Health Stroke Scale as a Predictor of Patient Recovery After Stroke.
Ash Jain, Douglas Van Houten, Lamiya Sheikh

J Cardiovasc Nurs· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
John R Laird, Ash Jain, Thomas Zeller, Robert Feldman, Dierk Scheinert

J Endovasc Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial.
Alan C Yeung, Martin B Leon, Ash Jain, Thaddeus R Tolleson, Douglas J Spriggs

J Am Coll Cardiol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.
Martin B Leon, Laura Mauri, Jeffrey J Popma, Donald E Cutlip, Eugenia Nikolsky, Ash Jain

J Am Coll Cardiol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis